nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Floxuridine—stomach cancer	0.676	1	CrCtD
Emtricitabine—Decitabine—Floxuridine—stomach cancer	0.236	1	CrCrCtD
Emtricitabine—DCK—Purine salvage—GMPR2—stomach cancer	0.00577	0.189	CbGpPWpGaD
Emtricitabine—DCK—Pyrimidine salvage reactions—TYMP—stomach cancer	0.00356	0.116	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—GMPR2—stomach cancer	0.00274	0.0895	CbGpPWpGaD
Emtricitabine—DCK—Pyrimidine metabolism—NT5E—stomach cancer	0.00203	0.0663	CbGpPWpGaD
Emtricitabine—DCK—Pyrimidine metabolism—UMPS—stomach cancer	0.00186	0.0607	CbGpPWpGaD
Emtricitabine—DCK—Pyrimidine metabolism—TYMP—stomach cancer	0.00162	0.053	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—NT5E—stomach cancer	0.00157	0.0514	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—GMPR2—stomach cancer	0.00138	0.045	CbGpPWpGaD
Emtricitabine—DCK—Pyrimidine metabolism—DPYD—stomach cancer	0.00129	0.0421	CbGpPWpGaD
Emtricitabine—DCK—Topotecan—Irinotecan—stomach cancer	0.00126	0.688	CbGdCrCtD
Emtricitabine—Floxuridine—TYMP—stomach cancer	0.00122	0.489	CrCbGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—RBP1—stomach cancer	0.000912	0.0298	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—NT5E—stomach cancer	0.000791	0.0258	CbGpPWpGaD
Emtricitabine—DCK—Pyrimidine metabolism—TYMS—stomach cancer	0.000733	0.024	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—UMPS—stomach cancer	0.000723	0.0236	CbGpPWpGaD
Emtricitabine—Decitabine—DNMT1—stomach cancer	0.000704	0.282	CrCbGaD
Emtricitabine—DCK—Nucleotide metabolism—TYMP—stomach cancer	0.000632	0.0207	CbGpPWpGaD
Emtricitabine—Floxuridine—TYMS—stomach cancer	0.000574	0.23	CrCbGaD
Emtricitabine—DCK—Nucleotide metabolism—DPYD—stomach cancer	0.000501	0.0164	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—DNMT1—stomach cancer	0.000373	0.0122	CbGpPWpGaD
Emtricitabine—DCK—Doxorubicin—Epirubicin—stomach cancer	0.000297	0.162	CbGdCrCtD
Emtricitabine—DCK—Nucleotide metabolism—TYMS—stomach cancer	0.000286	0.00933	CbGpPWpGaD
Emtricitabine—DCK—Epirubicin—Doxorubicin—stomach cancer	0.000275	0.15	CbGdCrCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—stomach cancer	0.000262	0.00855	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—stomach cancer	0.000204	0.00667	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ACAD8—stomach cancer	0.00014	0.00459	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	0.000138	0.00451	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	0.000132	0.00431	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	0.000127	0.00417	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GMPR2—stomach cancer	0.000125	0.00409	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SUCLG1—stomach cancer	0.000114	0.00374	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—IDH3B—stomach cancer	0.000114	0.00374	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NDUFS1—stomach cancer	0.000106	0.00347	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NDUFV1—stomach cancer	0.000106	0.00347	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	0.000106	0.00345	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PGLS—stomach cancer	9.48e-05	0.0031	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—BLVRB—stomach cancer	9.48e-05	0.0031	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PPAP2A—stomach cancer	9.04e-05	0.00295	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	8.68e-05	0.00284	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CA1—stomach cancer	8.06e-05	0.00263	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—FBP1—stomach cancer	8.06e-05	0.00263	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NDUFA2—stomach cancer	8.06e-05	0.00263	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CKB—stomach cancer	8.06e-05	0.00263	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PLIN2—stomach cancer	7.58e-05	0.00248	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CA2—stomach cancer	7.37e-05	0.00241	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NT5E—stomach cancer	7.18e-05	0.00235	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PGAM1—stomach cancer	7.18e-05	0.00235	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ALDH7A1—stomach cancer	6.85e-05	0.00224	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PLCE1—stomach cancer	6.85e-05	0.00224	CbGpPWpGaD
Emtricitabine—Hypokalaemia—Doxorubicin—stomach cancer	6.82e-05	0.00131	CcSEcCtD
Emtricitabine—Back pain—Capecitabine—stomach cancer	6.77e-05	0.0013	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—stomach cancer	6.77e-05	0.0013	CcSEcCtD
Emtricitabine—Body temperature increased—Irinotecan—stomach cancer	6.75e-05	0.0013	CcSEcCtD
Emtricitabine—Abdominal pain—Irinotecan—stomach cancer	6.75e-05	0.0013	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—stomach cancer	6.71e-05	0.00129	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—stomach cancer	6.7e-05	0.00129	CcSEcCtD
Emtricitabine—Anaemia—Docetaxel—stomach cancer	6.68e-05	0.00128	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—stomach cancer	6.67e-05	0.00128	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—stomach cancer	6.67e-05	0.00128	CcSEcCtD
Emtricitabine—Depression—Methotrexate—stomach cancer	6.65e-05	0.00128	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—stomach cancer	6.61e-05	0.00127	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—stomach cancer	6.61e-05	0.00127	CcSEcCtD
Emtricitabine—DCK—Metabolism—UMPS—stomach cancer	6.57e-05	0.00215	CbGpPWpGaD
Emtricitabine—Renal failure—Methotrexate—stomach cancer	6.55e-05	0.00126	CcSEcCtD
Emtricitabine—Neutropenia—Epirubicin—stomach cancer	6.54e-05	0.00126	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Epirubicin—stomach cancer	6.5e-05	0.00125	CcSEcCtD
Emtricitabine—Urticaria—Fluorouracil—stomach cancer	6.49e-05	0.00125	CcSEcCtD
Emtricitabine—Anaemia—Capecitabine—stomach cancer	6.47e-05	0.00124	CcSEcCtD
Emtricitabine—Body temperature increased—Fluorouracil—stomach cancer	6.46e-05	0.00124	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—stomach cancer	6.36e-05	0.00122	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—stomach cancer	6.35e-05	0.00122	CcSEcCtD
Emtricitabine—Weight decreased—Epirubicin—stomach cancer	6.33e-05	0.00122	CcSEcCtD
Emtricitabine—Hyperglycaemia—Epirubicin—stomach cancer	6.31e-05	0.00121	CcSEcCtD
Emtricitabine—Cough—Docetaxel—stomach cancer	6.31e-05	0.00121	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—stomach cancer	6.31e-05	0.00121	CcSEcCtD
Emtricitabine—Hypersensitivity—Irinotecan—stomach cancer	6.29e-05	0.00121	CcSEcCtD
Emtricitabine—Pneumonia—Epirubicin—stomach cancer	6.28e-05	0.00121	CcSEcCtD
Emtricitabine—Infestation NOS—Epirubicin—stomach cancer	6.24e-05	0.0012	CcSEcCtD
Emtricitabine—Infestation—Epirubicin—stomach cancer	6.24e-05	0.0012	CcSEcCtD
Emtricitabine—Arthralgia—Docetaxel—stomach cancer	6.16e-05	0.00118	CcSEcCtD
Emtricitabine—Myalgia—Docetaxel—stomach cancer	6.16e-05	0.00118	CcSEcCtD
Emtricitabine—Renal failure—Epirubicin—stomach cancer	6.13e-05	0.00118	CcSEcCtD
Emtricitabine—Asthenia—Irinotecan—stomach cancer	6.12e-05	0.00118	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Epirubicin—stomach cancer	6.12e-05	0.00118	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	6.11e-05	0.00118	CcSEcCtD
Emtricitabine—Cough—Capecitabine—stomach cancer	6.11e-05	0.00117	CcSEcCtD
Emtricitabine—DCK—Metabolism—ECHS1—stomach cancer	6.11e-05	0.002	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PDHA1—stomach cancer	6.11e-05	0.002	CbGpPWpGaD
Emtricitabine—Urinary tract infection—Epirubicin—stomach cancer	6.07e-05	0.00117	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—stomach cancer	6.06e-05	0.00116	CcSEcCtD
Emtricitabine—Hypersensitivity—Fluorouracil—stomach cancer	6.02e-05	0.00116	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—stomach cancer	6.02e-05	0.00116	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—stomach cancer	5.99e-05	0.00115	CcSEcCtD
Emtricitabine—Arthralgia—Capecitabine—stomach cancer	5.96e-05	0.00115	CcSEcCtD
Emtricitabine—Myalgia—Capecitabine—stomach cancer	5.96e-05	0.00115	CcSEcCtD
Emtricitabine—Haematuria—Epirubicin—stomach cancer	5.95e-05	0.00114	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—stomach cancer	5.94e-05	0.00114	CcSEcCtD
Emtricitabine—Anxiety—Capecitabine—stomach cancer	5.94e-05	0.00114	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	5.92e-05	0.00114	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—stomach cancer	5.91e-05	0.00114	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Epirubicin—stomach cancer	5.9e-05	0.00113	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—stomach cancer	5.87e-05	0.00113	CcSEcCtD
Emtricitabine—Infection—Docetaxel—stomach cancer	5.86e-05	0.00113	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—stomach cancer	5.86e-05	0.00113	CcSEcCtD
Emtricitabine—Sinusitis—Epirubicin—stomach cancer	5.85e-05	0.00113	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—stomach cancer	5.84e-05	0.00112	CcSEcCtD
Emtricitabine—Diarrhoea—Irinotecan—stomach cancer	5.84e-05	0.00112	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—stomach cancer	5.81e-05	0.00112	CcSEcCtD
Emtricitabine—Nervous system disorder—Docetaxel—stomach cancer	5.79e-05	0.00111	CcSEcCtD
Emtricitabine—Pruritus—Fluorouracil—stomach cancer	5.78e-05	0.00111	CcSEcCtD
Emtricitabine—Thrombocytopenia—Docetaxel—stomach cancer	5.78e-05	0.00111	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—stomach cancer	5.77e-05	0.00111	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—stomach cancer	5.77e-05	0.00111	CcSEcCtD
Emtricitabine—DCK—Metabolism—FADS1—stomach cancer	5.74e-05	0.00188	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—TYMP—stomach cancer	5.74e-05	0.00188	CbGpPWpGaD
Emtricitabine—Skin disorder—Docetaxel—stomach cancer	5.73e-05	0.0011	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—stomach cancer	5.68e-05	0.00109	CcSEcCtD
Emtricitabine—Infection—Capecitabine—stomach cancer	5.68e-05	0.00109	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—stomach cancer	5.66e-05	0.00109	CcSEcCtD
Emtricitabine—Dizziness—Irinotecan—stomach cancer	5.64e-05	0.00109	CcSEcCtD
Emtricitabine—Rhinitis—Epirubicin—stomach cancer	5.62e-05	0.00108	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—stomach cancer	5.61e-05	0.00108	CcSEcCtD
Emtricitabine—Nervous system disorder—Capecitabine—stomach cancer	5.6e-05	0.00108	CcSEcCtD
Emtricitabine—Hepatitis—Epirubicin—stomach cancer	5.6e-05	0.00108	CcSEcCtD
Emtricitabine—Diarrhoea—Fluorouracil—stomach cancer	5.59e-05	0.00108	CcSEcCtD
Emtricitabine—Thrombocytopenia—Capecitabine—stomach cancer	5.59e-05	0.00108	CcSEcCtD
Emtricitabine—Pharyngitis—Epirubicin—stomach cancer	5.56e-05	0.00107	CcSEcCtD
Emtricitabine—Skin disorder—Capecitabine—stomach cancer	5.55e-05	0.00107	CcSEcCtD
Emtricitabine—Urinary tract disorder—Epirubicin—stomach cancer	5.53e-05	0.00106	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—stomach cancer	5.51e-05	0.00106	CcSEcCtD
Emtricitabine—Connective tissue disorder—Epirubicin—stomach cancer	5.51e-05	0.00106	CcSEcCtD
Emtricitabine—Urethral disorder—Epirubicin—stomach cancer	5.49e-05	0.00106	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—stomach cancer	5.46e-05	0.00105	CcSEcCtD
Emtricitabine—Vomiting—Irinotecan—stomach cancer	5.43e-05	0.00104	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—stomach cancer	5.42e-05	0.00104	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—stomach cancer	5.41e-05	0.00104	CcSEcCtD
Emtricitabine—Dizziness—Fluorouracil—stomach cancer	5.41e-05	0.00104	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—stomach cancer	5.39e-05	0.00104	CcSEcCtD
Emtricitabine—Rash—Irinotecan—stomach cancer	5.38e-05	0.00103	CcSEcCtD
Emtricitabine—Dermatitis—Irinotecan—stomach cancer	5.38e-05	0.00103	CcSEcCtD
Emtricitabine—DCK—Metabolism—SREBF2—stomach cancer	5.38e-05	0.00176	CbGpPWpGaD
Emtricitabine—Musculoskeletal discomfort—Docetaxel—stomach cancer	5.38e-05	0.00103	CcSEcCtD
Emtricitabine—Headache—Irinotecan—stomach cancer	5.35e-05	0.00103	CcSEcCtD
Emtricitabine—Insomnia—Docetaxel—stomach cancer	5.34e-05	0.00103	CcSEcCtD
Emtricitabine—DCK—Metabolism—RORA—stomach cancer	5.31e-05	0.00174	CbGpPWpGaD
Emtricitabine—Paraesthesia—Docetaxel—stomach cancer	5.3e-05	0.00102	CcSEcCtD
Emtricitabine—Dyspnoea—Docetaxel—stomach cancer	5.26e-05	0.00101	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—stomach cancer	5.24e-05	0.00101	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—stomach cancer	5.21e-05	0.001	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Capecitabine—stomach cancer	5.2e-05	0.001	CcSEcCtD
Emtricitabine—Vomiting—Fluorouracil—stomach cancer	5.2e-05	0.000999	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—stomach cancer	5.2e-05	0.000999	CcSEcCtD
Emtricitabine—Dyspepsia—Docetaxel—stomach cancer	5.19e-05	0.000999	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—stomach cancer	5.18e-05	0.000997	CcSEcCtD
Emtricitabine—Insomnia—Capecitabine—stomach cancer	5.17e-05	0.000993	CcSEcCtD
Emtricitabine—Rash—Fluorouracil—stomach cancer	5.15e-05	0.000991	CcSEcCtD
Emtricitabine—Dermatitis—Fluorouracil—stomach cancer	5.15e-05	0.00099	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—stomach cancer	5.14e-05	0.000989	CcSEcCtD
Emtricitabine—Paraesthesia—Capecitabine—stomach cancer	5.13e-05	0.000986	CcSEcCtD
Emtricitabine—Headache—Fluorouracil—stomach cancer	5.12e-05	0.000985	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—stomach cancer	5.12e-05	0.000984	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Docetaxel—stomach cancer	5.09e-05	0.000979	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—stomach cancer	5.09e-05	0.000979	CcSEcCtD
Emtricitabine—Dyspnoea—Capecitabine—stomach cancer	5.09e-05	0.000979	CcSEcCtD
Emtricitabine—Fatigue—Docetaxel—stomach cancer	5.09e-05	0.000978	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—stomach cancer	5.08e-05	0.000977	CcSEcCtD
Emtricitabine—Nausea—Irinotecan—stomach cancer	5.07e-05	0.000975	CcSEcCtD
Emtricitabine—Immune system disorder—Epirubicin—stomach cancer	5.06e-05	0.000973	CcSEcCtD
Emtricitabine—Mediastinal disorder—Epirubicin—stomach cancer	5.05e-05	0.000971	CcSEcCtD
Emtricitabine—Pain—Docetaxel—stomach cancer	5.05e-05	0.00097	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—stomach cancer	5.04e-05	0.000969	CcSEcCtD
Emtricitabine—Dyspepsia—Capecitabine—stomach cancer	5.03e-05	0.000967	CcSEcCtD
Emtricitabine—DCK—Metabolism—ALDOB—stomach cancer	4.98e-05	0.00163	CbGpPWpGaD
Emtricitabine—Gastrointestinal disorder—Capecitabine—stomach cancer	4.93e-05	0.000948	CcSEcCtD
Emtricitabine—Fatigue—Capecitabine—stomach cancer	4.93e-05	0.000947	CcSEcCtD
Emtricitabine—Mental disorder—Epirubicin—stomach cancer	4.91e-05	0.000944	CcSEcCtD
Emtricitabine—Pain—Capecitabine—stomach cancer	4.89e-05	0.000939	CcSEcCtD
Emtricitabine—Malnutrition—Epirubicin—stomach cancer	4.88e-05	0.000938	CcSEcCtD
Emtricitabine—Nausea—Fluorouracil—stomach cancer	4.86e-05	0.000934	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Docetaxel—stomach cancer	4.83e-05	0.000928	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—stomach cancer	4.82e-05	0.000926	CcSEcCtD
Emtricitabine—Back pain—Epirubicin—stomach cancer	4.72e-05	0.000907	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—stomach cancer	4.68e-05	0.0009	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Capecitabine—stomach cancer	4.67e-05	0.000898	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—stomach cancer	4.67e-05	0.000898	CcSEcCtD
Emtricitabine—Body temperature increased—Docetaxel—stomach cancer	4.66e-05	0.000897	CcSEcCtD
Emtricitabine—Abdominal pain—Docetaxel—stomach cancer	4.66e-05	0.000897	CcSEcCtD
Emtricitabine—DCK—Metabolism—ALOX5—stomach cancer	4.63e-05	0.00151	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—DPYD—stomach cancer	4.55e-05	0.00149	CbGpPWpGaD
Emtricitabine—Cough—Methotrexate—stomach cancer	4.55e-05	0.000874	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—stomach cancer	4.54e-05	0.000873	CcSEcCtD
Emtricitabine—Urticaria—Capecitabine—stomach cancer	4.54e-05	0.000873	CcSEcCtD
Emtricitabine—Abdominal pain—Capecitabine—stomach cancer	4.52e-05	0.000868	CcSEcCtD
Emtricitabine—Body temperature increased—Capecitabine—stomach cancer	4.52e-05	0.000868	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—stomach cancer	4.51e-05	0.000868	CcSEcCtD
Emtricitabine—Anaemia—Epirubicin—stomach cancer	4.51e-05	0.000867	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—stomach cancer	4.44e-05	0.000853	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—stomach cancer	4.44e-05	0.000853	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	4.41e-05	0.000847	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—stomach cancer	4.36e-05	0.000839	CcSEcCtD
Emtricitabine—Hypersensitivity—Docetaxel—stomach cancer	4.35e-05	0.000836	CcSEcCtD
Emtricitabine—Cough—Epirubicin—stomach cancer	4.26e-05	0.000818	CcSEcCtD
Emtricitabine—Asthenia—Docetaxel—stomach cancer	4.23e-05	0.000814	CcSEcCtD
Emtricitabine—Infection—Methotrexate—stomach cancer	4.23e-05	0.000812	CcSEcCtD
Emtricitabine—Hypersensitivity—Capecitabine—stomach cancer	4.21e-05	0.000809	CcSEcCtD
Emtricitabine—Pruritus—Docetaxel—stomach cancer	4.17e-05	0.000803	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—stomach cancer	4.17e-05	0.000802	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—stomach cancer	4.17e-05	0.000802	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—stomach cancer	4.16e-05	0.000801	CcSEcCtD
Emtricitabine—Arthralgia—Epirubicin—stomach cancer	4.15e-05	0.000798	CcSEcCtD
Emtricitabine—Myalgia—Epirubicin—stomach cancer	4.15e-05	0.000798	CcSEcCtD
Emtricitabine—Anxiety—Epirubicin—stomach cancer	4.14e-05	0.000795	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—stomach cancer	4.13e-05	0.000794	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	4.12e-05	0.000793	CcSEcCtD
Emtricitabine—Asthenia—Capecitabine—stomach cancer	4.1e-05	0.000788	CcSEcCtD
Emtricitabine—Pruritus—Capecitabine—stomach cancer	4.04e-05	0.000777	CcSEcCtD
Emtricitabine—Diarrhoea—Docetaxel—stomach cancer	4.04e-05	0.000776	CcSEcCtD
Emtricitabine—DCK—Metabolism—GSTT1—stomach cancer	4.03e-05	0.00132	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CYP2A6—stomach cancer	3.98e-05	0.0013	CbGpPWpGaD
Emtricitabine—Infection—Epirubicin—stomach cancer	3.95e-05	0.00076	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—stomach cancer	3.94e-05	0.000757	CcSEcCtD
Emtricitabine—Diarrhoea—Capecitabine—stomach cancer	3.91e-05	0.000752	CcSEcCtD
Emtricitabine—Nervous system disorder—Epirubicin—stomach cancer	3.9e-05	0.00075	CcSEcCtD
Emtricitabine—Dizziness—Docetaxel—stomach cancer	3.9e-05	0.00075	CcSEcCtD
Emtricitabine—Thrombocytopenia—Epirubicin—stomach cancer	3.9e-05	0.000749	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—stomach cancer	3.87e-05	0.000745	CcSEcCtD
Emtricitabine—DCK—Metabolism—AKR1C3—stomach cancer	3.87e-05	0.00127	CbGpPWpGaD
Emtricitabine—Skin disorder—Epirubicin—stomach cancer	3.87e-05	0.000743	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—stomach cancer	3.85e-05	0.00074	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—stomach cancer	3.84e-05	0.000739	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—stomach cancer	3.84e-05	0.000739	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—stomach cancer	3.83e-05	0.000736	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—stomach cancer	3.82e-05	0.000734	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	3.82e-05	0.000733	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—stomach cancer	3.79e-05	0.000729	CcSEcCtD
Emtricitabine—Dizziness—Capecitabine—stomach cancer	3.78e-05	0.000726	CcSEcCtD
Emtricitabine—DCK—Metabolism—ENO1—stomach cancer	3.77e-05	0.00123	CbGpPWpGaD
Emtricitabine—Vomiting—Docetaxel—stomach cancer	3.75e-05	0.000721	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—stomach cancer	3.74e-05	0.00072	CcSEcCtD
Emtricitabine—Rash—Docetaxel—stomach cancer	3.72e-05	0.000715	CcSEcCtD
Emtricitabine—Dermatitis—Docetaxel—stomach cancer	3.72e-05	0.000715	CcSEcCtD
Emtricitabine—Headache—Docetaxel—stomach cancer	3.7e-05	0.000711	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—stomach cancer	3.67e-05	0.000706	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—stomach cancer	3.67e-05	0.000705	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—stomach cancer	3.66e-05	0.000703	CcSEcCtD
Emtricitabine—Pain—Methotrexate—stomach cancer	3.64e-05	0.000699	CcSEcCtD
Emtricitabine—Vomiting—Capecitabine—stomach cancer	3.63e-05	0.000698	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Epirubicin—stomach cancer	3.63e-05	0.000697	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—stomach cancer	3.61e-05	0.000694	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—stomach cancer	3.61e-05	0.000693	CcSEcCtD
Emtricitabine—Rash—Capecitabine—stomach cancer	3.6e-05	0.000693	CcSEcCtD
Emtricitabine—Insomnia—Epirubicin—stomach cancer	3.6e-05	0.000692	CcSEcCtD
Emtricitabine—Dermatitis—Capecitabine—stomach cancer	3.6e-05	0.000692	CcSEcCtD
Emtricitabine—Headache—Capecitabine—stomach cancer	3.58e-05	0.000688	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—stomach cancer	3.58e-05	0.000688	CcSEcCtD
Emtricitabine—Paraesthesia—Epirubicin—stomach cancer	3.57e-05	0.000687	CcSEcCtD
Emtricitabine—Dyspnoea—Epirubicin—stomach cancer	3.55e-05	0.000682	CcSEcCtD
Emtricitabine—Nausea—Docetaxel—stomach cancer	3.5e-05	0.000674	CcSEcCtD
Emtricitabine—Dyspepsia—Epirubicin—stomach cancer	3.5e-05	0.000674	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—stomach cancer	3.48e-05	0.000669	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Epirubicin—stomach cancer	3.44e-05	0.000661	CcSEcCtD
Emtricitabine—Fatigue—Epirubicin—stomach cancer	3.43e-05	0.00066	CcSEcCtD
Emtricitabine—Pain—Epirubicin—stomach cancer	3.4e-05	0.000654	CcSEcCtD
Emtricitabine—DCK—hematopoietic system—stomach cancer	3.4e-05	0.187	CbGeAlD
Emtricitabine—Nausea—Capecitabine—stomach cancer	3.39e-05	0.000652	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—stomach cancer	3.38e-05	0.00065	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—stomach cancer	3.36e-05	0.000646	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—stomach cancer	3.36e-05	0.000646	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.36e-05	0.000645	CcSEcCtD
Emtricitabine—DCK—Metabolism—CD44—stomach cancer	3.35e-05	0.00109	CbGpPWpGaD
Emtricitabine—Insomnia—Doxorubicin—stomach cancer	3.33e-05	0.00064	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—stomach cancer	3.31e-05	0.000636	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—stomach cancer	3.28e-05	0.000631	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Epirubicin—stomach cancer	3.25e-05	0.000626	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—stomach cancer	3.24e-05	0.000623	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.18e-05	0.000611	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—stomach cancer	3.17e-05	0.00061	CcSEcCtD
Emtricitabine—Urticaria—Epirubicin—stomach cancer	3.16e-05	0.000608	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—stomach cancer	3.15e-05	0.000605	CcSEcCtD
Emtricitabine—Abdominal pain—Epirubicin—stomach cancer	3.15e-05	0.000605	CcSEcCtD
Emtricitabine—Body temperature increased—Epirubicin—stomach cancer	3.15e-05	0.000605	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—stomach cancer	3.13e-05	0.000602	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—stomach cancer	3.05e-05	0.000587	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—stomach cancer	3.01e-05	0.000579	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—stomach cancer	3.01e-05	0.000578	CcSEcCtD
Emtricitabine—Hypersensitivity—Epirubicin—stomach cancer	2.93e-05	0.000564	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—stomach cancer	2.93e-05	0.000562	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—stomach cancer	2.91e-05	0.00056	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—stomach cancer	2.91e-05	0.00056	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—stomach cancer	2.91e-05	0.000559	CcSEcCtD
Emtricitabine—Asthenia—Epirubicin—stomach cancer	2.86e-05	0.000549	CcSEcCtD
Emtricitabine—DCK—Metabolism—PPP2R1A—stomach cancer	2.85e-05	0.00093	CbGpPWpGaD
Emtricitabine—Pruritus—Epirubicin—stomach cancer	2.82e-05	0.000541	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—stomach cancer	2.81e-05	0.000541	CcSEcCtD
Emtricitabine—DCK—Metabolism—GSTP1—stomach cancer	2.79e-05	0.000912	CbGpPWpGaD
Emtricitabine—DCK—pancreas—stomach cancer	2.77e-05	0.152	CbGeAlD
Emtricitabine—DCK—Metabolism—HMOX1—stomach cancer	2.75e-05	0.000899	CbGpPWpGaD
Emtricitabine—Diarrhoea—Epirubicin—stomach cancer	2.72e-05	0.000524	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—stomach cancer	2.71e-05	0.000522	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—stomach cancer	2.7e-05	0.00052	CcSEcCtD
Emtricitabine—Rash—Methotrexate—stomach cancer	2.68e-05	0.000516	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—stomach cancer	2.68e-05	0.000515	CcSEcCtD
Emtricitabine—Headache—Methotrexate—stomach cancer	2.66e-05	0.000512	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—stomach cancer	2.64e-05	0.000508	CcSEcCtD
Emtricitabine—Dizziness—Epirubicin—stomach cancer	2.63e-05	0.000506	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—stomach cancer	2.61e-05	0.000501	CcSEcCtD
Emtricitabine—DCK—Metabolism—TYMS—stomach cancer	2.59e-05	0.000848	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTM1—stomach cancer	2.56e-05	0.000838	CbGpPWpGaD
Emtricitabine—Vomiting—Epirubicin—stomach cancer	2.53e-05	0.000487	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—stomach cancer	2.53e-05	0.000486	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—stomach cancer	2.52e-05	0.000484	CcSEcCtD
Emtricitabine—Rash—Epirubicin—stomach cancer	2.51e-05	0.000482	CcSEcCtD
Emtricitabine—Dermatitis—Epirubicin—stomach cancer	2.51e-05	0.000482	CcSEcCtD
Emtricitabine—Headache—Epirubicin—stomach cancer	2.49e-05	0.000479	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—stomach cancer	2.44e-05	0.000468	CcSEcCtD
Emtricitabine—DCK—Metabolism—ERCC2—stomach cancer	2.41e-05	0.000788	CbGpPWpGaD
Emtricitabine—DCK—lymphoid tissue—stomach cancer	2.39e-05	0.132	CbGeAlD
Emtricitabine—Nausea—Epirubicin—stomach cancer	2.36e-05	0.000455	CcSEcCtD
Emtricitabine—DCK—digestive system—stomach cancer	2.36e-05	0.13	CbGeAlD
Emtricitabine—Vomiting—Doxorubicin—stomach cancer	2.34e-05	0.00045	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—stomach cancer	2.32e-05	0.000446	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—stomach cancer	2.32e-05	0.000446	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—stomach cancer	2.31e-05	0.000444	CcSEcCtD
Emtricitabine—DCK—Metabolism—MTHFR—stomach cancer	2.27e-05	0.000741	CbGpPWpGaD
Emtricitabine—Nausea—Doxorubicin—stomach cancer	2.19e-05	0.000421	CcSEcCtD
Emtricitabine—DCK—bone marrow—stomach cancer	2.18e-05	0.12	CbGeAlD
Emtricitabine—DCK—Metabolism—CAV1—stomach cancer	2.09e-05	0.000683	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—APOA1—stomach cancer	2.09e-05	0.000682	CbGpPWpGaD
Emtricitabine—DCK—endocrine gland—stomach cancer	1.95e-05	0.108	CbGeAlD
Emtricitabine—DCK—Metabolism—PPARG—stomach cancer	1.84e-05	0.000601	CbGpPWpGaD
Emtricitabine—DCK—liver—stomach cancer	1.76e-05	0.0969	CbGeAlD
Emtricitabine—DCK—Metabolism—ALB—stomach cancer	1.65e-05	0.00054	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NOS3—stomach cancer	1.58e-05	0.000517	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PTGS2—stomach cancer	1.45e-05	0.000473	CbGpPWpGaD
Emtricitabine—DCK—lymph node—stomach cancer	1.35e-05	0.0743	CbGeAlD
Emtricitabine—DCK—Metabolism—PIK3CA—stomach cancer	8.9e-06	0.000291	CbGpPWpGaD
